1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Blood Vessel Prosthesis: new trials by email Literature Review of Blood Vessel Prosthesis trials Research Report on Blood Vessel Prosthesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts Tissue Engineered Vascular Grafts - HLH - Hypoplastic Left Heart Syndrome, DORV | Phase 2 | Recruiting | Nationwide Children's Hospital | 24 | 2020-07-15 | 2025-06-27 |
| Use of a Lifeline Graft in the A-V Shunt Model Lifeline - ESRD, Hemodialysis | Phase 1 / Phase 2 | Completed | Cytograft Tissue Engineering | 2004-09-01 | 2013-07-17 |
Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Hypoplastic Left Heart Syndrome (1) · Kidney Failure, Chronic (1) · Tricuspid Atresia (1) · Univentricular Heart (1)
Cytograft Tissue Engineering (1) · Nationwide Children's Hospital (1)
Argentina (1) · Poland (1) · United States (1)
Christopher Breuer, MD (1) · Lech Cierpka, MD PhD (1) · Mark Galantowicz, MD (1) · Toshiharu Shinoka, MD/PhD (1)
5UH3HL148693 (1), R44HL064462 (1)